日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer

靶向 Syndecan-1 的治疗性抗体可抑制巨胞饮作用,并在胰腺癌中诱导抗肿瘤免疫。

Zecheng Yang,Madelaine S Theardy,Shuaitong Chen,Yongkun Wei,Mitsunobu Takeda,Yue Zeng,Xiaofei Wang,Jun Yao,Jennifer Li,Prapassorn Thirasastr,Jangho Park,Yangxi Zheng,Long T Vien,Khalida M Wani,Huamin Wang,Sisi Gao,Tim Heffernan,Lawrence Kwong,Ignacio I Wistuba,Laura Bover,Giulio F Draetta,Haoqiang Ying,Wantong Yao

Epigenome editing of human hematopoietic stem cells enables sustained and reversible thrombosis prevention

对人类造血干细胞进行表观基因组编辑可实现持续且可逆的血栓预防。

Ye, Tianyi; Xu, Wanying; Barrachina, Maria N; Lyu, Peng; Antoszewski, Mateusz; Volpe, Lucrezia Della; Guo, Chun-Jie; Lee, Andrew J; Theardy, Madelaine S; Shelton, Spencer D; Wahlster, Lara; Caulier, Alexis; Messa, Luana; Poeschla, Michael; Agarwal, Gaurav; Mitra, Ronodeep; Schmaier, Alec A; Weissman, Jonathan S; Machlus, Kellie R; Sankaran, Vijay G

KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer

KRAS抑制激活胰腺癌中可发挥作用的CD24“别吃我”信号

Yongkun Wei ,Minghui Liu # ,Er-Yen Yen # ,Jun Yao # ,Zhenzhen Xun ,Phuoc T Nguyen ,Xiaofei Wang ,Zecheng Yang ,Abdelrahman Yousef ,Dean Pan ,Yanqing Jin ,Ching-Fei Li ,Madelaine S Theardy ,Jangho Park ,Yiming Cai ,Mitsunobu Takeda ,Matthew Vasquez ,Elizabeth M Park ,David H Peng ,Yong Zhou ,Hong Zhao ,Timothy P Heffernan ,Andrea Viale ,Huamin Wang ,Stephanie S Watowich ,Han Liang ,Dan Zhao ,Ronald A DePinho ,Wantong Yao ,Haoqiang Ying

Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers

靶向 Syndecan-1 轴的治疗可以克服胃肠道癌症中对 KRAS 靶向治疗的获得性耐药性

Madelaine S Theardy ,Mitsunobu Takeda ,Alexey Sorokin ,Shuaitong Chen ,Zecheng Yang ,Xiaofei Wang ,Preeti Kanikarla ,Oluwadara Coker ,Phuoc Nguyen ,Yongkun Wei ,Jun Yao ,Liang Yan ,Yanqing Jin ,Yiming Cai ,Masakatsu Paku ,Ziheng Chen ,Kara Z Li ,Francesca Citron ,Hideo Tomihara ,Sisi Gao ,Angela K Deem ,Jun Zhao ,Huamin Wang ,Samir Hanash ,Ronald A DePinho ,Anirban Maitra ,Giulio F Draetta ,Haoqiang Ying ,Scott Kopetz ,Wantong Yao

Modeling oxaliplatin resistance in colorectal cancer reveals a SERPINE1-based gene signature (RESIST-M) and therapeutic strategies for pro-metastatic CMS4 subtype.

对结直肠癌中奥沙利铂耐药性的建模揭示了基于 SERPINE1 的基因特征 (RESIST-M) 和促转移 CMS4 亚型的治疗策略

Wong Stephen Qi Rong, Das Mohua, Tenzin Kenzom, Shirgaonkar Niranjan, Chua Huiwen, Chee Lin Xuan, Sae Yeoh Ahpa, Murugiah Astley Aruna, Chua Wei Yong, Theardy Madelaine Skolastika, Subel Ethan Jadon, Thangavelu Matan Thangavelu, Chan Jane Vin, Yap Choon Kong, Tan Iain Bee Huat, Tsantoulis Petros, Tejpar Sabine, Loo Jia Min, DasGupta Ramanuj

Targeting dual oncogenic machineries driven by TAL1 and PI3K-AKT pathways in T-cell acute lymphoblastic leukemia

靶向 T 细胞急性淋巴细胞白血病中由 TAL1 和 PI3K-AKT 通路驱动的双重致癌机制

Fang Qi Lim, Allison Si-Yu Chan, Rui Yokomori, Xiao Zi Huang, Madelaine Skolastika Theardy, Allen Eng Juh Yeoh, Shi Hao Tan, Takaomi Sanda

IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphoma

IRF4 在斑马鱼 T 细胞淋巴瘤模型中驱动克隆进化和谱系选择

Stella Amanda #, Tze King Tan #, Jolynn Zu Lin Ong, Madelaine Skolastika Theardy, Regina Wan Ju Wong, Xiao Zi Huang, Muhammad Zulfaqar Ali, Yan Li, Zhiyuan Gong, Hiroshi Inagaki, Ee Yong Foo, Brendan Pang, Soo Yong Tan, Shinsuke Iida, Takaomi Sanda

IRF4 as an Oncogenic Master Transcription Factor

IRF4 作为致癌主转录因子

Wong, Regina Wan Ju; Ong, Jolynn Zu Lin; Theardy, Madelaine Skolastika; Sanda, Takaomi